From Gangs to Activism, Learning from Antong Lucky and his Redemptive Path

 

A path to redemption paved with inspiration is most rewarding. For Antong Lucky, inspiring others and sharing wisdom from his many trials and tribulations is his passion and his life’s mission. Former founder and leader of the Dallas 415 Bloods Gang, Lucky’s journey in and out of the U.S. prison system, as well as a deeply personal journey of self-discovery, led him to eventually renounce his gang ties and work to build avenues for reentering formerly incarcerated people into society, launching violence reduction strategies, and mentoring black men and boys. As the Urban Specialists Master Educator and National Engagement Director for OGU (Original Gangstas University) and an accomplished author and activist, Lucky now uses his skills to teach others how to move through life with a credo of peace and resolve conflicts without violence; Lucky’s unique journey has led to his emergence as a leader in the movement to heal America. 

It’s no surprise that Tuesdays with Morrisey’s Adam Morrisey wanted to have Lucky on the podcast to not only reconnect with a friend and professional colleague, but share his story with others to offer relevant insights on living a life of determination, healing, and community-building. Morrisey was fascinated to learn more about how Lucky connected the dots from his past to the present and created a powerful influence with government and community leaders.  

“The underlying thread that took me from the drug house to the White House was the fact that I really believed and embodied redemption and transformation that we all are entitled to,” Lucky said. “We’ve all made some mistakes in our past that we don’t care to admit. But those mistakes don’t define who we are.” 

During Morrisey and Lucky’s conversation, they discuss:  

  • The mentors that inspired and shaped Lucky’s path to redemption
  • Strategy and initiatives happening with the Urban Specialists
  • Lucky’s memoir, A Redemptive Path Forward
  • Lucky’s relationship with the late Bishop Omar, founder of Urban Specialists, and Omar’s legacy

“The late great Bishop Omar was one of the smartest people I’ve ever met in my lifetime,” Lucky said. “He spent his entire life helping and adding meaning to other people’s lives. His personality was so big that whenever he walked into a room, everybody just drew to him. He could provide a solution to every problem.” 

Antong Lucky is the author of A Redemptive Path Forward: From Incarceration to a Life of Activism. He is the President of The Urban Specialists and Co-Chair of Heal America. Lucky has devoted the last twenty years to ending violence in communities by training OGs (Original Gangstas) across the country to effectively mentor youth away from a life in gangs, crime, and violence. 

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More